IE
SPRB

Israel Englander’s Spruce Biosciences SPRB Stock Holding History

Israel Englander’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.69M Buy
160,981
+49,093
+44% +$2.74M ﹤0.01% 2431
2026
Q1 		$7.31M Buy
+111,888
New +$7.72M ﹤0.01% 2517
2024
Q2 		– Sell
-1,363
Closed -$80.3K – 6668
2024
Q1 		$80.3K Sell
1,363
-5,443
-80% -$1.38M ﹤0.01% 5617
2023
Q4 		$1.5M Sell
6,806
-974
-13% -$113K ﹤0.01% 3839
2023
Q3 		$1.32M Buy
7,780
+78
+1% +$13.1K ﹤0.01% 3957
2023
Q2 		$1.24M Sell
7,702
-416
-5% -$69.6K ﹤0.01% 3866
2023
Q1 		$1.35M Buy
8,118
+6,151
+313% +$1.14M ﹤0.01% 3814
2022
Q4 		$162K Buy
1,967
+33
+2% +$2.76K ﹤0.01% 5409
2022
Q3 		$199K Sell
1,934
-601
-24% -$84K ﹤0.01% 5670
2022
Q2 		$331K Buy
+2,535
New +$325K ﹤0.01% 5289
2021
Q4 		– Sell
-515
Closed -$232K – 7488
2021
Q3 		$232K Buy
515
+285
+124% +$179K ﹤0.01% 6014
2021
Q2 		$193K Sell
230
-744
-76% -$794K ﹤0.01% 6035
2021
Q1 		$1.21M Sell
974
-689
-41% -$1.06M ﹤0.01% 4022
2020
Q4 		$3.03M Buy
+1,663
New +$2.76M ﹤0.01% 2887

Other funds holding SPRB

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Israel Englander's SPRB Position: Q2 2026 in Review

Israel Englander increased its Spruce Biosciences (SPRB) stake by 44% in Q2 2026, buying an estimated $2.74M and bringing the position to 160,981 shares worth $8.69M. The position accounts for ﹤0.01% of the portfolio, ranked #2431.

Israel Englander first reported a position in SPRB in Q4 2020 and has held it in 14 quarters since. 63 funds tracked by Wall St. Rank hold SPRB as of Q2 2026.

  • Israel Englander held 160,981 shares of Spruce Biosciences worth $8.69M as of Q2 2026.
  • Israel Englander bought 49,093 Spruce Biosciences shares in Q2 2026, an estimated $2.74M.
  • Spruce Biosciences made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2431 holding.
  • Israel Englander first reported a position in Spruce Biosciences in Q4 2020 and has held it in 14 quarters since.
  • 63 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.